Affordable Access

deepdyve-link
Publisher Website

Enteric coating of oral solid dosage forms as a tool to improve drug bioavailability.

Authors
  • Maderuelo, Cristina1
  • Lanao, Jose M2
  • Zarzuelo, Aránzazu1
  • 1 Pharmaceutical Sciences Department, University of Salamanca, C/Licenciado Méndez Nieto s/n, 37007 Salamanca, Spain. , (Spain)
  • 2 Pharmaceutical Sciences Department, University of Salamanca, C/Licenciado Méndez Nieto s/n, 37007 Salamanca, Spain; Institute of Biomedical Research of Salamanca (IBSAL), Spain. Electronic address: [email protected] , (Spain)
Type
Published Article
Journal
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Publication Date
Jul 30, 2019
Volume
138
Pages
105019–105019
Identifiers
DOI: 10.1016/j.ejps.2019.105019
PMID: 31374253
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Enteric coating is a common procedure in the development of oral pharmaceutical dosage forms. The main advantage of enteric coating is that it protects the drug from acidic pH and enzymatic degradation in the stomach while protecting it from the undesirable effects of some drugs. There is certain controversy regarding the real influence of enteric coating on the bioavailability of many drugs. Various scientific articles have demonstrated an improvement in the extent of bioavailability of some drugs when enteric coating is used. In recent years, there have been many studies examining different formulation strategies for monolithic and multiparticulate systems, including different pharmaceutical oral dosage forms and delivery systems based on the combined use of enteric coating and other methods that improve the bioavailability of drugs administered orally. However, the real bioavailability, serum levels and therapeutic effect of these drugs may be influenced by gastrointestinal pH values, gastrointestinal environment, inter-individual or intra-individual variability in gastric emptying and gastrointestinal transit time, interpatient variability associated with the type of polymer used for enteric coating or other formulation variables. It deserves special attention to know the real influence of enteric coating on the bioavailability of new oral dosage forms. Copyright © 2019. Published by Elsevier B.V.

Report this publication

Statistics

Seen <100 times